COR to Expand Retina Consultants of America With $1.1B EyeSouth DealZacks Investment Research • 03/24/26
Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners' Retina BusinessBusiness Wire • 03/23/26
Here's Why You Should Hold Cencora Stock in Your Portfolio for NowZacks Investment Research • 03/17/26
Cencora, Inc. (COR) Presents at Leerink Global Healthcare Conference 2026 TranscriptSeeking Alpha • 03/10/26
Cencora, Inc. (COR) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptSeeking Alpha • 03/10/26
COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion DealZacks Investment Research • 02/19/26
Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056Business Wire • 02/10/26
Cencora Stock Down Despite Q1 Earnings Beat, Gross Margin ImprovesZacks Investment Research • 02/04/26
Cencora (COR) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 02/04/26
Exploring Analyst Estimates for Cencora (COR) Q1 Earnings, Beyond Revenue and EPSZacks Investment Research • 01/30/26
Can Specialty and International Momentum Support Cencora's Q1 Results?Zacks Investment Research • 01/29/26
Curant Rare Announces Collaboration with Cencora to Support Commercialization of Rare and Orphan Drug ProductsBusiness Wire • 01/22/26